title: Granulomatous lung disease occurring during etanercept treatment.
authors.affiliation: Brigham and Women's Hospital, Boston, Massachussetts 02115, USA.
authors.forename: Kristine
authors.initials: K
authors.lastname: Phillips
authors.forename: Michael
authors.initials: M
authors.lastname: Weinblatt
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D000068800:Etanercept; D006105:Granulomatous Disease, Chronic / Q000139:chemically induced*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007155:Immunologic Factors / Q000009:adverse effects*; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept